Tool: DupCheckTool: DupCheck

www.DupCheck.org is a web-based tool to screen for duplicate patients in clinical trials within and across studies, sponsors and therapeutic areas. Please visit our "Tools" page for more information.


Project FlyerProject Flyer


Click here to download 
the NEWMEDS project flyer! 


ConsortiumConsortium
consortium teaser

QuicklinksQuicklinks
Project Office Project Office Annual PGB and WP Leads Meetings Annual PGB and WP Leads Meetings Project Governance Project Governance Funding Mechanisms Funding Mechanisms




  Members Area
Username:
Password:



EU
IMI | The Innovative Medicines Initiative
EFPIA | European Federation of Pharmaceutical Industries and Associations

logo PSYNOVA

Psynova Neurotech Ltd.
St. John's Innovation Centre; Cowley Rd.,
CB4 0WS
Cambridge,
UK

Psynova www.psynova.com



Participant's Lead


Paul Rodgers Paul Rodgers
Chairman 
E-Mail to Paul Rodgers Contact  
 



Institute Presentation


Psynova Neurotech was established in 2005 by Dr Sabine Bahn, MD, PhD, MRCPsych, and Prof Chris Lowe, PhD of the University of Cambridge to build on 12 years of ground-breaking research by Dr Bahn in identifying novel biomarkers for neuropsychiatric illnesses. Psynova is collaborating with Rules Based Medicine (RBM) Inc. to co-develop a candidate biomarker panel into a clinical test to aid in the early diagnosis and treatment of schizophrenia. Psynova expects this will be the first of several products in related therapeutic areas to address this unmet clinical need for objective molecular tests in psychiatric disorders. Psynova is also the co-ordinator of an 8 member consortium that has been awarded a European Commission Framework 7 grant to develop minimally invasive, high throughput, low cost molecular assays for the early diagnosis of schizophrenia and other psychiatric disorders.


08 Psynova Neurotech Ltd